Meryl A Butters, PhD
Education & Training
Selected Honors & Awards
- Diniz, BS, Sibille, E, Ding, Y, Tseng,G, HJ, Lotrich,F, Becker,JT, Lopez, OL, Lotze,MT, Klunk,WE, Reynolds, CF, Butters MA. Plasma Biosignature and Brain Pathology related to Persistent Cognitive Impairment in Late-Life Depression. Mol Psych. 2015;May;20(5):594-601.
- Butters MA, Bhalla, RK, Andreescu, C, Wetherell, JL, Mantella, R, Begley, AE, Lenze, EJ. Changes in neuropsychological functioning following treatment for late-life Generalized Anxiety Disorder. Br J Psychiatry. 2011;199(3):211-218.
- Butters MA, Young JB, Lopez OL, Aizenstein HJ, Mulsant BH, Reynolds CF, DeKosky ST, Becker JT. Pathways linking late-life depression to persistent cognitive impairment and dementia. Dialogues Clin Neurosci. 2008;10(3):345-357.
- Butters MA, Whyte E, Nebes RD, Begley AE, Dew MA, Mulsant BH, Zmuda MD, Bhalla R, Meltzer CC, Pollock BG, Reynolds CF, Becker JT. The nature and determinants of neuropsychological functioning in late-life depression. Arch Gen Psychiatry. 2004;61(6);587-595.
- Butters MA, Becker JT, Nebes RD, Zmuda MD, Mulsant BH, Pollock BG, Reynolds, CF. Changes in cognitive functioning following treatment for late-life depression. Am J Psychiatry. 2000;157:1949-1954.
Magnetic Resonance Imaging Predictors of Pharmacotherapy Response in Major Depressive Disorder
Major depressive disorder is among the most prevalent psychiatric disorders, affecting nearly 300 million people worldwide, and exacting a substantial personal, social, and economic toll. Antidepressant treatment typically involves an individualized trial-and-error approach with an inconsistent success rate. Given the negative outcomes associated with depression, there is a pressing need for the development of...
Pitt Psychiatry Investigators Report New Findings in Alzheimer’s Disease and Dementia & Late-Life Depression Research
Acta Neuropathologica: Plasma P-Tau231, A New Biomarker for Incipient Alzheimer's Disease Pathology Scientists including Tharick Pascoal, MD, PhD (Assistant Professor of Psychiatry and Neurology) from Pitt Psychiatry have published the discovery and validation of a new blood biomarker of Alzheimer’s disease which, for the first time, can produce remarkably early detection of the pathology. The quantification of...
Meryl Butters, PhD, Honored by the Massachusetts Neuropsychological Society
Congratulations to Meryl Butters, PhD, Professor of Psychiatry and Clinical and Translational Science. Dr. Butters has been awarded the Edith Kaplan Award, which is given biannually by the Massachusetts Neuropsychological Society to a clinician/researcher in the field of neuropsychology who has continued to uphold the theory of the Process Approach to Neuropsychology. Dr. Butters is nationally and internationally...
University of Pittsburgh School of Medicine Promotes Meryl Butters, PhD, to Professor of Psychiatry
We are delighted to announce that Meryl Butters, PhD, has been promoted to Professor of Psychiatry by the University of Pittsburgh School of Medicine. Dr. Butters is an internationally recognized expert in geriatric mental health. Through her exploration of the interface of depression and cognitive decline, she has contributed important new insights related to our understanding of dementia symptoms in the elderly...